Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Moxifloxacin Hydrochloride Injection

Approval Number

国药准字H20213879

Company山西威奇达光明制药有限公司

Registration Date

November 24, 2021

Drug Information

Generic Name

盐酸莫西沙星注射液

Dosage Form

注射剂

Strength

20ml：0.4g（按C21H24FN3O4计）

Drug Type

化学药品

Registration Date

November 24, 2021

Company Information

Applicant Company

Company Name山西威奇达光明制药有限公司

Company Address

大同经济技术开发区第一医药园区

Manufacturing Company

Company Name山西威奇达光明制药有限公司

Company Address

山西省大同市经济技术开发区第一医药园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy